Update on CIHR Funding Opportunities in Commercialization

(2010-01-29) CIHR is committed to facilitating the commercialization of health research in Canada in support of its overall mandate and is offering a suite of updated programs at "View All Current Opportunities" tab:

i) Proof of Principle (POP): Phase I or Phase II

For academic researchers aiming to commercialize a new concept (and partners for Phase II). Next deadline March 1st 2010.

New this year:

• Increased maximum grant amounts
• Increased total funding
• More favourable funding ratio for the partner (Phase II)

ii) Operating Grant - Industry-partnered Collaborative Research (2009-2010)
[Note: replaces Rx&D Operating Grant and SME Operating Grant]

For collaborative research projects bringing together academic researchers and a private sector partner. Next deadline February 15, 2010 (registration).

New this year:

• More favourable funding ratio for the partner
• Level of partner engagement now a factor in the rating process
• Randomized Controlled Trials (RCTs) are now eligible

iii) Other - Science to Business (2009-2010) MBA scholarship

For those holding a recent PhD in a health-related field and wanting to pursue an MBA as a next step to a career supporting innovation in Canada. Next deadline March 1st 2010.

New this year:

• Students apply directly to CIHR
• Revised award amount
• Eligibility no longer limited to MBA programs with a health-stream